MENU
BLTE
AS OF
Dec 24 closing price
Price
$155.00
Change
+$0.50 (+0.32%)
Capitalization
5.81B
92 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
BLTE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Belite Bio (BLTE) Ownership - Who owns Belite Bio?

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
12750 High Bluff Drive
Phone
+1 858 246-6240
Employees
20
Web
https://www.belitebio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.81B
P/E Ratio
N/A
Total Cash
275.61M
Projected Growth
N/A
Total Debt
510K
Revenue
N/A
Risk (Beta)
-0.38
Dividend Yield
N/A
Total Cash/Share
7.35
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

BLTE
Capitalization
5.82B
P/E Ratio
N/A
Risk (Beta)
-0.38
Dividend Yield
N/A
Total Cash
276M
Total Cash/Share
7.35
Total Debt
510K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
274M
P/B Ratio
21.23
Cash Flow
N/A
Earnings
-1.92
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
34.37
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-63.25M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-31.33
Shares Held By Institutions
173M
Shares Outstanding - Current
37.5M
Total Liabilities
8.31M
Total Volume MTD
N/A
Value
N/A
Gain YTD
145.642
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
BLTE
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BLTE showed earnings on November 10, 2025. You can read more about the earnings report here.
View AI-Driven Trading for BLTE
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
12750 High Bluff Drive
Phone
+1 858 246-6240
Employees
20
Web
https://www.belitebio.com